BeyondSpring Inc. (BYSI)
Latest BYSI Insider Trades
About BeyondSpring Inc. (BYSI)
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment. Its first asset, Plinabulin is a novel brain-penetrant microtubule modulator with dendritic cell maturation and vasculature modulation mechanism, which has the potential to help mitigate acquired resistance from prior immune checkpoint inhibitors (ICI) treatment in cancer patients. It is a Selective Immunomodulating Microtubule-Binding Agent (SIMBA), which may provide multiple therapeutic opportunities.
- FLORHAM PARK, NJ
- 44
- 2017
- XNAS
https://www.beyondspringpharma.comSEC filings for BYSI on EDGAR
90-Day SEC Filing Activity
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 2 | 200,000 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
BYSI Insider Transactions (Form 4)
7327 Form 4 filings on record, the earliest from Aug 11, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Grant or award | Stock Options (right to buy) | 100,000 |
Recent BYSI Form 8-K Filings
5BYSI Insider Trading - FAQ
What is the latest insider trade for BYSI?
BeyondSpring Inc. (BYSI) had 2 insider filings in the last 90 days, with the most recent on 2026-07-06. The full record for BYSI runs to 27 Form 4 filings, the earliest from 2025-08-11. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying BYSI stock?
No insider purchases of BYSI were filed in the last 90 days.
How many insiders are selling BYSI stock?
No insider sales of BYSI were filed in the last 90 days. 63 sales are on record for this company.
Where can I see BYSI SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks BYSI Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow BYSI insider buys?
Create a free InsiderAlpha account and press Watch on this page to add BYSI to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Jiangwen Majeti view on EDGAR
- - Min Qiu view on EDGAR
- - Lan Huang view on EDGAR
- - Matthew Kirkby view on EDGAR
- - Patrick Fabbio view on EDGAR
- - Brendan Delaney view on EDGAR
- - Jiangwen Majeti view on EDGAR
- - Yingjuan June Lu view on EDGAR
- - Lan Huang view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where BYSI's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track BYSI insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.